Apoptosis
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
What is Apoptosis? The Apoptotic Pathways and the Caspase Cascade
Targets for Apoptosis
- Pyroptosis(32)
- Caspase(68)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(41)
- Bax(8)
- Bcl-2 Family(122)
- Bcl-xL(8)
- c-RET(8)
- IAP(27)
- KEAP1-Nrf2(70)
- MDM2(13)
- p53(124)
- PC-PLC(4)
- PKD(7)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(149)
- Other Apoptosis(884)
- Apoptosis Detection(0)
- Caspase Substrate(0)
- APC(6)
- PD-1/PD-L1 interaction(91)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Cuproptosis(3)
Products for Apoptosis
- Cat.No. Product Name Information
-
GC16278
A-1210477
MCL-1 inhibitor
-
GC17513
A-1331852
BCL-XL inhibitor, potent and selective
-
GC60544
A-192621
A-192621 is a potent, nonpeptide, orally active and selective endothelin B (ETB) receptor antagonist with an IC50 of 4.5 nM and a Ki of 8.8 nM.
-
GC32981
A-385358
A-385358 is a selective inhibitor of Bcl-XL with Kis of 0.80 and 67 nM for Bcl-XL and Bcl-2, respectively.
-
GC91113
A011
An inhibitor of ATM kinase
-
GC11200
A23187
Calcimycin
A23187, free acid is a Ca2+ ionophore
-
GC42659
A23187 (calcium magnesium salt)
Calcimycin
A23187 is a divalent cation ionophore.
-
GC35216
AAPK-25
AAPK-25 is a potent and selective Aurora/PLK dual inhibitor with anti-tumor activity, which can cause mitotic delay and arrest cells in a prometaphase, reflecting by the biomarker histone H3Ser10 phosphorylation and followed by a surge in apoptosis. AAPK-25 targets Aurora-A, -B, and -C with Kd values ranging from 23-289 nM, as well as PLK-1, -2, and -3 with Kd values ranging from 55-456 nM.
-
GC13805
Abacavir
-
GC64674
ABBV-167
ABBV-167 is a phosphate prodrug of the BCL-2 inhibitor venetoclax.
-
GC73269
ABBV-467
ABBV-467 is a selective MCL-1 inhibitor (Ki: <0.01 nM).
-
GC42677
ABO (hydrochloride)
ABO is a modulator of annexin A7.
-
GC60548
ABT-100
ABT-100 is a potent, highly selective and orally active farnesyltransferase inhibitor. ABT-100 inhibits cell proliferation (IC50s of 2.2 nM, 3.8 nM, 5.9 nM, 6.9 nM, 9.2 nM, 70 nM and 818 nM for EJ-1, DLD-1, MDA-MB-231, HCT-116, MiaPaCa-2, PC-3, and DU-145 cells, respectively), increases apoptosis and decreases angiogenesis. ABT-100 possesses broad-spectrum antitumor activity.
-
GC14069
ABT-199
GDC 0199, Venetoclax
Venetoclax (ABT-199, GDC-0199) is a selective inhibitor of Bcl-2 with a K i of 0.01 nM in cell-free assays. -
GC12405
ABT-263 (Navitoclax)
Navitoclax,ABT-263,ABT263,ABT 263
ABT-263 (Navitoclax) is a inhibitor of Bcl-xL, Bcl-2 and Bcl-w, with Ki ≤0.5 nM, ≤1 nM and ≤1 nM respectively. -
GC49745
ABT-263-d8
Navitoclax-d8
ABT-263-d8 is the deuterium labeled Navitoclax. Navitoclax (ABT-263) is a potent and orally active Bcl-2 family protein inhibitor that binds to multiple anti-apoptotic Bcl-2 family proteins, such as Bcl-xL, Bcl-2 and Bcl-w, with a Ki of less than 1 nM. -
GC70733
ABT-510 acetate
ABT-510 acetate is an anti-angiogenic TSP peptide (Thrombospondin-1 analogue) that induces apoptosis and inhibits ovarian tumour growth in an orthotopic, syngeneic model of epithelial ovarian cancer.
-
GC17234
ABT-737
ABT 737, ABT737
An inhibitor of anti-apoptotic Bcl-2 proteins -
GC90489
AC 187 (trifluoroacetate salt)
An antagonist of calcitonin and amylin receptors
-
GC40122
Ac-AAVALLPAVLLALLAP-DEVD-CHO (trifluoroacetate salt)
Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Asp-Glu-Val-Asp-CHO, Ac-AAVALLPAVLLALLAP-DEVD-aldehyde, Ac-AAVALLPAVLLALLAPDEVD-CHO, Caspase-3 Inhibitor I, DEVD-CHO-CPP 32
Ac-AAVALLPAVLLALLAP-DEVD-CHO is a composite of Ac-DEVD-CHO, a peptide inhibitor of caspase-3 and -7, and a cell-permeable hydrophobic sequence derived from K-FGF. -
GC40118
Ac-AAVALLPAVLLALLAP-IETD-CHO (trifluoroacetate salt)
Ac-Ala-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Ile-Glu-Thr-Asp-CHO, Caspase-8 Inhibitor I
Ac-AAVALLPAVLLALLAP-IETD-CHO is a composite of Ac-IETD-CHO, a peptide inhibitor of caspase-8, and a cell-permeable hydrophobic sequence derived from K-FGF. -
GC40123
Ac-AAVALLPAVLLALLAP-VAD-CHO (trifluoroacetate salt)
Caspase Inhibitor II, Ac-AAVALLPAVLLALLAP-VAD-aldehyde, Ac-AAVALLPAVLLALLAPVAD-CHO
Ac-AAVALLPAVLLALLAP-VAD-CHO is a composite of Ac-VAD-CHO, a non-selective caspase inhibitor, and a cell-permeable hydrophobic sequence derived from K-FGF. -
GA20494
Ac-Asp-Glu-Val-Asp-pNA
Ac-Asp-Glu-Val-Asp-pNA
The cleavage of the chromogenic caspase-3 substrate Ac-DEVD-pNA can be monitored at 405 nm. -
GC17602
Ac-DEVD-AFC
N-Acetyl-Asp-Glu-Val-Asp-7-amido-4-Trifluoromethylcoumarin,Caspase-3 Substrate (Fluorogenic)
fluorogenic substrate for activated caspase-3 -
GC32695
Ac-DEVD-CHO
Ac-DEVD-CHO is a Caspase-3 inhibitor with an IC50 value of 0.016μM.
-
GC48470
Ac-DEVD-CHO (trifluoroacetate salt)
N-Ac-Asp-Glu-Val-Asp-CHO
A dual caspase3/caspase7 inhibitor -
GC10951
Ac-DEVD-CMK
Ac-Asp-Glu-Val-Asp-CMK,Caspase-3 Inhibitor III
cell-permeable, and irreversible inhibitor of caspase -
GC48430
Ac-DEVD-CMK (trifluoroacetate salt)
AcAspGluValAspCMK, Caspase3 Inhibitor III
-
GC68600
Ac-DEVD-CMK TFA
Caspase-3 Inhibitor III TFA
Ac-DEVD-CMK (Caspase-3 Inhibitor III) TFA is a selective and irreversible inhibitor of caspase-3. Ac-DEVD-CMK TFA significantly inhibits apoptosis induced by high levels of glucose or 3,20-dibenzoate (IDB; 5). Ac-DEVD-CMK TFA can be used in various experimental methods to inhibit cell apoptosis.
-
GC42687
Ac-DMQD-AMC (trifluoroacetate salt)
Ac-Asp-Met-Gln-Asp-AMC, Ac-Asp-Met-Gln-Asp-7-amino-4-methylcoumarin
Ac-DMQD-AMC is a fluorogenic substrate for caspase-3. -
GC42688
Ac-DMQD-CHO (trifluoroacetate salt)
Ac-Asp-Met-Gln-Asp-CHO, Caspase-3 Inhibitor
Ac-DMQD-CHO is a peptide inhibitor of caspase-3 (IC50 = 39 nM). -
GC42689
Ac-DNLD-AMC
Ac-Asp-Asn-Leu-Asp-MCA, N-Acetyl-Asp-Asn-Leu-Asp-7-amido-Methylcoumarin, Caspase-3 Substrate
Ac-WLA-AMC is a fluorogenic substrate of caspase-3. -
GC40154
Ac-ESMD-CHO (trifluoroacetate salt)
Ac-Glu-Ser-Met-Asp-CHO
Ac-ESMD-CHO is an inhibitor of caspase-3 maturation. -
GC65107
Ac-FEID-CMK TFA
Ac-FEID-CMK TFA is a potent zebrafish-specific GSDMEb-derived peptide inhibitor.
-
GC60558
Ac-FLTD-CMK
Ac-FLTD-CMK, a gasdermin D (GSDMD)-derived inhibitor, is a specific inflammatory caspases inhibitor.
-
GC49704
Ac-FLTD-CMK (trifluoroacetate salt)
Ac-Phe-Leu-Thr-Asp-CMK
An inhibitor of caspase-1, -4, -5, and -11 -
GC40152
Ac-IEPD-pNA (trifluoroacetate salt)
Ac-Ile-Glu-Pro-Asp-p-nitroanilide, Caspase-8 Chromogenic Substrate, Granzyme B Substrate VIII
Ac-IEPD-pNA is a colorimetric substrate for granzyme B and caspase-8. -
GC40164
Ac-IETD-CHO (trifluoroacetate salt)
Caspase-8 Inhibitor
Ac-IETD-CHO is an inhibitor of caspase-8 (IC50 = 5 nM).
-
GC42708
Ac-LEHD-AFC (trifluoroacetate salt)
N-Acetyl-Leu-Glu-His-Asp-7-amino-4-Trifluoromethylcoumarin, Caspase-9 substrate (Fluorogenic)
Ac-LEHD-AFC is a fluorogenic substrate that can be cleaved by caspase-4, -5, and -9. -
GC18226
Ac-LEHD-AMC (trifluoroacetate salt)
Ac-Leu-Glu-His-Asp-AMC, Caspase-9 Substrate
Ac-LEHD-AMC (trifluoroacetate salt) is a fluorogenic substrate for caspase-9 (Excitation: 341 nm; Emission: 441 nm). -
GC46791
Ac-LEHD-pNA (trifluoroacetate salt)
Ac-Leu-Glu-His-Asp-pNA, Caspase-9 Chromogenic Substrate I
A neuropeptide with diverse biological activities -
GC40556
Ac-LETD-AFC
NAcetylLeuGluThrAsp7amino4Trifluoromethylcoumarin, Caspase8 Substrate (Fluorogenic)
Ac-LETD-AFC is a fluorogenic substrate that can be cleaved specifically by caspase-8. -
GC42709
Ac-LEVD-CHO (trifluoroacetate salt)
Ac-Leu-Glu-Val-Asp-CHO, Caspase-4 Inhibitor I
Ac-LEVD-CHO is a caspase-4 inhibitor.
-
GC13400
Ac-VDVAD-AFC
N-Acetyl-Val-Asp-Val-Ala-Asp-7-amino-4-Trifluoromethylcoumarin Caspase-2 Substrate (Fluorogenic)
Ac-VDVAD-AFC is a caspase-specific fluorescent substrate. Ac-VDVAD-AFC can measure caspase-3-like activity and caspase-2 activity and can be used for the research of tumor and cancer. -
GC52372
Ac-VDVAD-AFC (trifluoroacetate salt)
N-Acetyl-Val-Asp-Val-Ala-Asp-AFC, N-Acetyl-Val-Asp-Val-Ala-Asp-7-amino-4-Trifluoromethylcoumarin, Caspase-2 Substrate (Fluorogenic)
A fluorogenic substrate for caspase-2 -
GC42716
Ac-VDVAD-pNA (trifluoroacetate salt)
Ac-Val-Asp-Val-Ala-Asp-pNA, Caspase-2 Chromogenic Substrate, acetyl-Val-Asp-Val-Ala-Asp-p-nitroanilide, acetyl-VDVAD-p-nitroanilide
Ac-VDVAD-pNA is a colorimetric substrate for caspase-2. -
GC48974
Ac-VEID-AMC (ammonium acetate salt)
NAcetylValGluIleAsp7amido4Methylcoumarin, Caspase6 Substrate (Fluorogenic)
A caspase-6 fluorogenic substrate -
GC42718
Ac-VEID-CHO (trifluoroacetate salt)
Ac-Val-Glu-Ile-Asp-CHO
Ac-VEID-CHO is an inhibitor of caspase-6 (IC50 = 16.2 nM). -
GC70289
AC-VEID-CHO TFA
AC-VEID-CHO (TFA) is a peptide-derived caspase inhibitor and has potency of inhibition for Caspase-6, Caspase-3 and Caspase-7 with IC50 values of 16.2 nM, 13.6 nM and 162.1 nM, respectively.
-
GC40162
Ac-VEID-pNA (trifluoroacetate salt)
Ac-Val-Glu-Ile-Asp-pNA, Ac-Val-Glu-Ile-Asp-p-nitroanilide, Caspase-6 Chromogenic Substrate
Ac-VEID-pNA is a substrate for caspase-6. -
GC74380
Ac-VRPR-AMC TFA
Ac-VRPR-AMC TFA is a fluorogenic metacaspase substrate.
-
GC40124
Ac-WEAD-AMC (trifluoroacetate salt)
Ac-Trp-Glu-Ala-Asp-AMC
Ac-WEAD-AMC is a fluorogenic substrate for caspase-1 and caspase-4. -
GC42719
Ac-WEAD-pNA (trifluoroacetate salt)
Ac-Trp-Glu-Ala-Asp-pNA, Ac-Trp-Glu-Ala-Asp-p-nitroanilide, Caspase-1 and Caspase-4 Chromogenic Substrate
Ac-WEAD-pNA is a colorimetric substrate for caspase-1 and caspase-4. -
GC46796
Ac-WEHD-AFC (trifluoroacetate salt)
N-Acetyl-Trp-Glu-His-Asp-7-amino-4-Trifluoromethylcoumarin, Caspase1 Substrate (Fluorogenic), Caspase5 Substrate (Fluorogenic)
A neuropeptide with diverse biological activities -
GC68621
Ac-WEHD-AFC TFA
Ac-WEHD-AFC TFA is a fluorescent substrate for caspase-1. It can detect the fluorescence activity of caspase-1 and is used in research on tumors and inflammation.
-
GC18021
Ac-YVAD-CHO
Caspase-1 Inhibitor I, L 709049, N-Ac-Tyr-Val-Ala-Asp-CHO
Selective inhibitor of interleukin-1β converting enzyme (ICE; Caspase-1) -
GC42721
Ac-YVAD-CMK
N-Ac-Tyr-Val-Ala-Asp-CMK
Ac-YVAD-CMK is a selective irreversible inhibitor of caspase-1 (Ki=0.8nM), which can prevent the proinflammatory cytokine IL-1β activation. Ac-YVAD-CMK can reduce the inflammatory response and induce a long-lasting neuroprotective effect. -
GC74500
Acasunlimab
GEN1046
Acasunlimab (GEN1046) is a bispecific antibody (bsAb) targeting PD-L1 and 4-1BB. -
GC35227
ACBI1
ACBI1 is a potent and cooperative SMARCA2, SMARCA4 and PBRM1 degrader with DC50s of 6, 11 and 32 nM, respectively. ACBI1 is a PROTAC degrader. ACBI1 shows anti-proliferative activity. ACBI1 induces apoptosis.
-
GN10341
Acetate gossypol
-
GC11786
Acetylcysteine
N-acetylcysteine; N-acetyl-L-cysteine; NAC; Acetadote
Acetylcysteine is the N-acetyl derivative of CYSTEINE. -
GC17094
Acitretin
all-trans Acitretin, Ro 10-1670, Ro 10-1670/000
Metabolite of etretinate
-
GC35242
Actein
Actein is a triterpene glycoside isolated from the rhizomes of Cimicifuga foetida. Actein suppresses cell proliferation, induces autophagy and apoptosis through promoting ROS/JNK activation, and blunting AKT pathway in human bladder cancer. Actein has little toxicity in vivo.
-
GC16866
Actinomycin D
Cosmegen, Dactinomycin, Meractinomycin, NCI C04682, NSC 3053, Oncostatin K
Actinomycin D (dactinomycin) is a natural chromopeptide isolated from Streptomyces species, and has one heterocyclic chromophore and two cyclic pentapeptide lactone rings. [1] -
GC70584
Actinomycin X2
Actinomycin X2 (Actinomycin V), produced by many Streptomyces sp.
-
GC16350
Actinonin
(-)-Actinonin,Ro 06-1467
Peptidomimetic antibiotic that inhibits aminopeptidases
-
GC16362
AD57 (hydrochloride)
polypharmacological cancer therapeutic that inhibits RET.
-
GC34214
Adalimumab (Anti-Human TNF-alpha, Human Antibody)
Adalimumab (Anti-Human TNF-alpha, Human Antibody) is one of the leading therapies for the treatment of rheumatoid arthritis.
-
GC10610
Adapalene
CD 271
RARβ and RARγ agonist -
GC46798
Adapalene-d3
An internal standard for the quantification of adapalene
-
GC13959
Adarotene
ST1926
An atypical retinoid -
GC74501
Adebrelimab
SHR-1316
Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody. -
GC65880
ADH-6 TFA
ADH-6 TFA is a tripyridylamide compound. ADH-6 abrogates self-assembly of the aggregation-nucleating subdomain of mutant p53 DBD. ADH-6 TFA targets and dissociates mutant p53 aggregates in human cancer cells, which restores p53's transcriptional activity, leading to cell cycle arrest and apoptosis. ADH-6 TFA has the potential for the research of cancer diseases.
-
GC42735
Adipostatin A
NSC 776, 5-pentadecyl Resorcinol
Adipostatin A (Adipostatin A) is a glycerol-3-phosphate dehydrogenase (GPDH) inhibitor with an IC50 of 4.1 μM. -
GC11892
AEE788 (NVP-AEE788)
NVP-AEE788
AEE788 (NVP-AEE788) is an inhibitor of the EGFR and ErbB2 with IC50 values of 2 and 6 nM, respectively. -
GC42743
AEM1
Cancer cell survival appears partly dependent on antioxidative enzymes, whose expression is regulated by the Keap1-Nrf2 pathway, to quench potentially toxic reactive oxygen species generated by their metastatic transformation.
-
GC72386
Afelimomab
Afelimomab (MAK 195F) is an anti-tumor necrosis factor F(ab')2 monoclonal antibody fragment.
-
GC13168
AG 825
Tyrphostin AG825
Selective ErbB2 inhibitor -
GC13697
AG-1024
AGS 200, Tyrphostin AG1024
AG-1024 is a reversible, competitive and selective insulin-like growth factor-1 receptor (IGF-1R) inhibitor with an IC50 value of 7µM. AG-1024 can inhibit the phosphorylation of insulin receptor (IR) with an IC50 value of 57µM. -
GC17881
AGK 2
AGK2 is a selective SIRT2 inhibitor, with an IC50 of 3.5 µM. AGK2 inhibits SIRT1 and SIRT3 with IC50 of 30 and 91 µM, respectively.
-
GC39584
AGN194204
IRX4204; NRX194204; VTP 194204
AGN194204 (IRX4204) is an orally active and selective RXR agonist with Kd values 0.4 nM, 3.6 nM and 3.8 nM and EC50s of 0.2 nM, 0.8 nM and 0.08 nM for RXRα, RXRβ and RXRγ, respectively. -
GC16120
AI-3
Nrf2/Keap1 and Keap1/Cul3 interaction inhibitor
-
GC46821
Ajoene
A disulfide with diverse biological activities
-
GC68632
AK-778-XXMU
AK-778-XXMU is an effective inhibitor of DNA binding 2 (ID2) antagonist, with a KD of 129 nM. AK-778-XXMU can inhibit the migration and invasion of glioma cell lines, induce apoptosis, and more importantly, slow down tumor growth.
-
GC39620
AKOS-22
-
GC11589
AKT inhibitor VIII
A potent inhibitor of Akt1 and Akt2
-
GC35275
AKT-IN-3
AKT-IN-3 (compound E22) is a potent, orally active low hERG blocking Akt inhibitor, with 1.4 nM, 1.2 nM and 1.7 nM for Akt1, Akt2 and Akt3, respectively. AKT-IN-3 (compound E22) also exhibits good inhibitory activity against other AGC family kinases, such as PKA, PKC, ROCK1, RSK1, P70S6K, and SGK. AKT-IN-3 (compound E22) induces apoptosis and inhibits metastasis of cancer cells.
-
GC19897
Albendazole Sulfone
ABZ-SO2, ABZ-SOO
Analytical Standards
-
GC49773
Albendazole sulfone-d3
ABZ-SO2-d3, ABZ-SOO-d3
An internal standard for the quantification of albendazole sulfone -
GC48848
Albendazole-d7
ABZ-d7
An internal standard for the quantification of albendazole -
GC41080
Albofungin
Antibiotic P42-1, Antibiotic P42-C
Albofungin is a xanthone isolated from A. -
GC16597
Alda 1
ALDH2 activator
-
GC73642
ALK-IN-26
ALK-IN-26 is an ALK inhibitor with IC50 value of 7.0 μM for ALK tyrosine kinase.
-
GC35288
Alkannin
(-)-Alkannin, NSC 94524
A naphthoquinone with diverse biological activities -
GC40094
all-trans Retinoic Acid-d5
atRA-d5, RA-d5, Vitamin A Acid-d5
all-trans Retinoic acid-d5 is intended for use as an internal standard for the quantification of all-trans retinoic acid by GC- or LC-MS. -
GC49393
all-trans-13,14-Dihydroretinol
A metabolite of all-trans retinoic acid
-
GC32127
Alofanib (RPT835)
RPT835
Alofanib (RPT835) (RPT835) is a potent and selective allosteric inhibitor of fibroblast growth factor receptor 2 (FGFR2). -
GC14314
Aloperine
An alkaloid
-
GC35306
alpha-Mangostin
alpha-Mangostin (α-Mangostin) is a dietary xanthone with broad biological activities, such as antioxidant, anti-allergic, antiviral, antibacterial, anti-inflammatory and anticancer effects. It is an inhibitor of mutant IDH1 (IDH1-R132H) with a Ki of 2.85 μM.
-
GC18437
Alternariol monomethyl ether
AME, NSC 638262
Alternariol monomethyl ether, isolated from the roots of Anthocleista djalonensis (Loganiaceae), is an important taxonomic marker of the plant species.